Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Dhingra

Showing results (231-240 of 264) with videos related to

Pageof 27
Sort By:
Journal of Clinical Medicine|July 27, 2024
Patient Reported Outcome Measures in Adults with Fontan Circulatory FailureGuillermo Agorrody, Isaac Begun, Subodh Verma, et al.
Cancer|June 11, 2015
Variation in symptom distress in underserved Chinese American cancer patientsLara K Dhingra, Kin Lam, William Cheung, et al.
ACS Infectious Diseases|October 31, 2018
Identification and Mechanistic Understanding of Dihydroorotate Dehydrogenase Point Mutations in Plasmodium falciparum that Confer in Vitro Resistance to the Clinical Candidate DSM265John White, Satish K Dhingra, Xiaoyi Deng, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 27, 2021
Mitral repair with leaflet preservation versus leaflet resection and ventricular reverse remodeling from a randomized trialMakoto Hibino, Nitish K Dhingra, Subodh Verma, et al.
The Lancet. Diabetes & Endocrinology|December 3, 2021
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trialSubodh Verma, Nitish K Dhingra, Javed Butler, et al.
The Canadian Journal of Cardiology|November 2, 2025
When Bad Things Happen to Good Hearts; Prediction and Management of Primary Graft DysfunctionNitish K Dhingra, Farid Foroutan, Lauren K Truby, et al.
Plos Pathogens|February 7, 2022
Evidence for the early emergence of piperaquine-resistant Plasmodium falciparum malaria and modeling strategies to mitigate resistanceJennifer L Small-Saunders, Laura M Hagenah, Kathryn J Wicht, et al.
Mbio|May 11, 2017
A Variant PfCRT Isoform Can Contribute to <i>Plasmodium falciparum</i> Resistance to the First-Line Partner Drug PiperaquineSatish K Dhingra, Devasha Redhi, Jill M Combrinck, et al.
The Cancer Journal From Scientific American|August 5, 1998
Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node statusH M Kuerer, L A Newman, A U Buzdar, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2001
Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breastA Hoque, S M Lippman, I V Boiko, et al.
Pageof 27

Showing results (231-240 of 264) with videos related to

Sort By:
Pageof 27
Journal of Clinical Medicine|July 27, 2024
Patient Reported Outcome Measures in Adults with Fontan Circulatory FailureGuillermo Agorrody, Isaac Begun, Subodh Verma, et al.
Cancer|June 11, 2015
Variation in symptom distress in underserved Chinese American cancer patientsLara K Dhingra, Kin Lam, William Cheung, et al.
ACS Infectious Diseases|October 31, 2018
Identification and Mechanistic Understanding of Dihydroorotate Dehydrogenase Point Mutations in Plasmodium falciparum that Confer in Vitro Resistance to the Clinical Candidate DSM265John White, Satish K Dhingra, Xiaoyi Deng, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 27, 2021
Mitral repair with leaflet preservation versus leaflet resection and ventricular reverse remodeling from a randomized trialMakoto Hibino, Nitish K Dhingra, Subodh Verma, et al.
The Lancet. Diabetes & Endocrinology|December 3, 2021
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trialSubodh Verma, Nitish K Dhingra, Javed Butler, et al.
The Canadian Journal of Cardiology|November 2, 2025
When Bad Things Happen to Good Hearts; Prediction and Management of Primary Graft DysfunctionNitish K Dhingra, Farid Foroutan, Lauren K Truby, et al.
Plos Pathogens|February 7, 2022
Evidence for the early emergence of piperaquine-resistant Plasmodium falciparum malaria and modeling strategies to mitigate resistanceJennifer L Small-Saunders, Laura M Hagenah, Kathryn J Wicht, et al.
Mbio|May 11, 2017
A Variant PfCRT Isoform Can Contribute to <i>Plasmodium falciparum</i> Resistance to the First-Line Partner Drug PiperaquineSatish K Dhingra, Devasha Redhi, Jill M Combrinck, et al.
The Cancer Journal From Scientific American|August 5, 1998
Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node statusH M Kuerer, L A Newman, A U Buzdar, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2001
Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breastA Hoque, S M Lippman, I V Boiko, et al.
Pageof 27